Zurich Cantonal Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Zurich Cantonal Bank’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,111	Closed	-$26K	–	2954
2022 Q1	$26K	Hold	13,111	–	–	﹤0.01%	2643
2021 Q4	$36K	Hold	13,111	–	–	﹤0.01%	2804
2021 Q3	$58K	Hold	13,111	–	–	﹤0.01%	2578
2021 Q2	$76K	Hold	13,111	–	–	﹤0.01%	2332
2021 Q1	$92K	Hold	13,111	–	–	﹤0.01%	2190
2020 Q4	$63K	Hold	13,111	–	–	﹤0.01%	2370
2020 Q3	$76K	Hold	13,111	–	–	﹤0.01%	2106
2020 Q2	$88K	Buy	+13,111	New	+$99.3K	﹤0.01%	2007
2019 Q4	–	Sell	-2,754	Closed	-$11K	–	2644
2019 Q3	$11K	Hold	2,754	–	–	﹤0.01%	2544
2019 Q2	$41K	Hold	2,754	–	–	﹤0.01%	2190
2019 Q1	$68K	Sell	2,754 -390	-12%	-$9.78K	﹤0.01%	1817
2018 Q4	$56K	Hold	3,144	–	–	﹤0.01%	1968
2018 Q3	$92K	Buy	3,144 +549	+21%	+$21.3K	﹤0.01%	1762
2018 Q2	$118K	Hold	2,595	–	–	﹤0.01%	1558
2018 Q1	$137K	Hold	2,595	–	–	﹤0.01%	1426
2017 Q4	$176K	Buy	2,595 +776	+43%	+$54.3K	﹤0.01%	1264
2017 Q3	$150K	Hold	1,819	–	–	﹤0.01%	1152
2017 Q2	$170K	Hold	1,819	–	–	﹤0.01%	1074
2017 Q1	$116K	Buy	1,819 +758	+71%	+$46.1K	﹤0.01%	1250
2016 Q4	$47K	Hold	1,061	–	–	﹤0.01%	1742
2016 Q3	$38K	Buy	1,061 +383	+56%	+$8.22K	﹤0.01%	1826
2016 Q2	$9K	Hold	678	–	–	﹤0.01%	2409
2016 Q1	$13K	Hold	678	–	–	﹤0.01%	2269
2015 Q4	$24K	Buy	678 +241	+55%	+$15.5K	﹤0.01%	1923
2015 Q3	$40K	Buy	437 +348	+391%	+$30.1K	﹤0.01%	1205
2015 Q2	$8K	Hold	89	–	–	﹤0.01%	1570
2015 Q1	$7K	Buy	+89	New	+$6.29K	﹤0.01%	1649

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Zurich Cantonal Bank's CLVS Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 13,111 shares — an estimated $26K sold.

Zurich Cantonal Bank first reported a position in CLVS in Q1 2015 and held it in 27 quarters. The position peaked at $176K in Q4 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

Zurich Cantonal Bank reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
Zurich Cantonal Bank sold 13,111 Clovis Oncology, Inc. shares in Q2 2022, an estimated $26K.
Zurich Cantonal Bank first reported a position in Clovis Oncology, Inc. in Q1 2015 and held it in 27 quarters.
Zurich Cantonal Bank's Clovis Oncology, Inc. position peaked at $176K in Q4 2017.
115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.